The biopharmaceutical industry has launched a declaration proposing a joint solution to global leaders that could help to ensure equitable access to vaccines and treatments for future pandemics.
The ‘Berlin Declaration – biopharmaceutical industry vision for equitable access in pandemics’ builds on a ‘deep analysis’ of the lessons learned from the COVID-19 pandemic. It proposes a framework that could help to ensure that pandemic vaccines, treatments and diagnostics are delivered as quickly as possible to priority populations in lower-income countries, as determined by health authorities.
